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Abstract
Background: All hematopoietic cells express P2 receptors, however pharmacological characteristics such as expression
and affinity in granulocytes are unknown.
Methods: Pharmacological characteristics of P2 receptors were evaluated by Ca2+ measurements using Fura-2
fluorophore. P2 receptors expression were analyzed by flow cytometry and RT-PCR. P2 interaction were shown by
coimmunoprecipitation, western blotting and FRET.
Results: Granulocytes were responsive to P2Y agonists, whereas P2X agonists were ineffective. Ca2+ increase, elicited
by ADP and UTP was dependent on intracellular stocks and sensitive to G-coupled receptor inhibition. Moreover,
MRS2179, a specific antagonist of the P2Y1 receptor, abolished ADP response. Interestingly, ADP and UTP exhibited full
heterologous desensitization, suggesting that these agonists interact with the same receptor. The heteromeric
association between P2Y1 receptor and the P2Y2 and P2Y4 receptors was shown by immunoprecipitation and FRET
analysis.
Conclusion: Clear evidence of heteromeric association of P2Y receptors was found during the evaluation of P2
receptors present in mice granulocytes, which could impact in the classical pharmacology of P2Y receptors in
granulocytes.
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Background
Many G protein-coupled receptors, such as those in the
P2 receptor family, form homo- or hetero-associations.
P2 receptors, which are activated by ATP and analogs,
are classified as metabotropic P2Y or ionotropic P2X
receptors. Heterodimerization involving P2X receptors is
well known and receptor heterodimers P2X2–3, P2X2–6,
P2X4–6 and P2X1–5 have been previously described
[1, 2]. Some studies have shown that some P2Y receptors
such as P2Y1 receptors, can form heteromeric association
with adenosine A1 receptor [3] and P2Y11 receptor [4].
Additionally, P2Y receptors can form constitutively
functional dimers or oligomers and homo- or hetero-
associations that can alter the pharmacology and intracel-
lular signaling of P2Y receptors [5–7]. Among P2Y
receptors, pyrimidine receptors seem to have appropriate
domains for interaction with other P2Y receptors [7].
ATP is the main physiological agonist that activates all
P2 receptors, except P2Y14 receptor [8]. Some P2Y
receptors (e.g., P2Y1, P2Y12 and P2Y13 receptors) can be
activated by purine diphosphates such as 2meSADP or
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ADP [9, 10]. Pyrimidines such as UTP activate P2Y2 and
P2Y4 receptors and UDP activates P2Y6 receptors [8, 11].
P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 receptors are mainly
Gq/11-protein coupled receptors, whereas P2Y12, P2Y13
and P2Y14 receptors are mainly Gi-protein-coupled
receptors [1, 10]. The only known P2 receptor capable of
triggering adenylate cyclase in response to ATPγS or ATP
is the P2Y11 receptor [12]. On the other hand, the ionic-
channel family of P2X1–7 receptors increases Na
+ and Ca2+
concentrations by competition. These receptors are acti-
vated by ATP, αβmeATP, βγmeATP and BzATP, whereas
ADP is only a partial agonist of P2X5 and P2X6 receptors
[13]. For P2X1–7 receptors, UTP does not activate any of
the seven P2X receptors.
In the present study, we observed that ADP and UTP
exhibited full heterologous desensitization in mice
granulocytes, suggesting that these agonists interact with
the same receptor. This unique phenomenon could be
possible due to the heteromeric association observed
between P2Y1/P2Y2 and P2Y1/P2Y4. These associations
could promote changes in the classical pharmacological
properties of P2Y receptors observed in granulocytes.
Methods
Chemicals
Adenosine 5’-triphosphate (ATP), α,β-methyleneade-
nosine 5′-triphosphate (αβMeATP), 2′-3′-O-(4-ben-
zoylbenzoyl)-adenosine 5’-triphosphate (BzATP), βγ-
methyleneadenosine 5’-triphosphate (βγMeATP),
adenosine 5′-diphosphate (ADP), pertussis toxin (PTX),
digitonin, hydrocortisone, Hystopaque (1119 and 1077)
solutions and 2′-deoxy-N6-methyl adenosine 3′,5′-di-
phosphate diammonium salt (MRS2179) were purchased
from Sigma Chemical Co. (MO, USA). Pluronic acid,
1-[6-[((17β)-3-Methoxyestra-1,3,5 [10]-trien-17-yl)ami-
no]hexyl]-1H-pyrrole-2,5-dione (U73122), ADP and
two different uridine 5′-triphosphates (UTP) were
purchased from Calbiochem (CA, USA). Trizol, agarose,
amplification grade deoxyribonuclease I, RnaseOUT-
Rnase inhibitor, TaqDNA polymerase, fura-2 acetoxy-
methyl ester (fura-2/AM), fluo-4/AM, Alexa Fluor
488-conjugated goat anti-rabbit IgG and Iscove’s
modified Dulbecco’s medium (IMDM) were obtained
from Invitrogen Life Technologies/Molecular Probes
(CA, USA). FACs lysing solution and the monoclonal
extracellular antibodies Phycoerythrin (PE)-conjugated
rat anti-Mac-1 and Cy7/PE-conjugated rat anti-Gr-1
were purchased from PharMingen Becton Dickinson
(CA, USA). The polyclonal rabbit anti-P2Y (P2Y1,
P2Y2, P2Y4, P2Y6, P2Y11 and P2Y12) antibodies were
purchased from Alomone Labs (Jerusalem, Israel).
Protein-A Sepharose was purchased from GE Healthcare
(USA). Horse serum was obtained from StemCell
Technologies Inc. (Vancouver, BC, Canada). All other
chemicals were acquired from Merck-Calbiochem (Rio de
Janeiro, Brazil). PTX and MRS2179 were diluted in water.
U73122 and fMLP were diluted in >0.001 % DMSO at
final concentration, controls were carried out to exclude
alterations induced by DMSO.
Isolation of granulocytes
Bone marrow was obtained from the femur bones of
3-month-old female C57BL/10 mice killed by rapid
cervical dislocation. Bone marrow cells were flushed
out from two femurs with Tyrode’s solution (3 ml)
with a fitted syringe. The experimental protocols for
animal care and use were reviewed and approved by
the Bioethics Committee of our Institution according
to the “Guide for the care and use of laboratory ani-
mals” approved by the Animal Care Ethics Committee
of the Federal University of São Paulo (1464/03).
Bone marrow cell types were separated by gradient
centrifugation with different density solutions. A pool of
bone marrow from six mice was suspended (6 ml) in
Hystopaque (d = 1.119 g/cm3, 3 ml and d = 1.077 g/cm3,
3 ml) and centrifuged (700 × g, 30 min), allowing separ-
ation of the cell types into distinct layers.
After separation of cell types, contaminants in the
granulocytic fraction were removed. Erythroid cells were
lysed with identical volumes of cool hypotonic (0.2 %)
and hypertonic (1.6 %) NaCl solutions. Mononuclear
contaminants were eliminated by centrifugation (200 × g,
10 min, 3 cycles) [14].
Calcium measurements
Measurements with calcium fluorophore fura-2 in cell
suspension
Cytoplasmic Ca2+ concentration ([Ca2+]cyt) was measured
in a loaded cell suspension (106 cells/ml) in Tyrode’s solu-
tion (137 mM NaCl, 2.68 mM KCl, 1.36 mM CaCl2,
0.49 mM MgCl2, 12 mM NaHCO3, 0.36 mM NaH2PO4,
and 5.5 mM D-glucose). Incubations with Ca2+ indicator
were performed at room temperature with fura-2/AM
(2 μM) and pluronic acid (0.02 %) under constant shaking
for 40 min approximately [15]. After incorporation of
fura-2, the cells were washed and suspended in Tyrode’s
solution (2.5 ml) and transferred to a quartz cuvette for
fluorometer measurements (SPEX FluoroLog-2, AR-CM
System). Changes in [Ca2+]cyt were measured at 37 °C with
alternated excitations at λEx 340 nm and 380 nm, and
emission was measured at λEm = 505 nm. The maximum
fluorescence ratio (Rmax) was determined after disruption
of the cell plasma membranes with digitonin (50 μM), and
a minimum fluorescence ratio (Rmin) was obtained with
MnCl2 (2 mM), followed by addition of EGTA (10 mM) in
alkaline medium. [Ca2+]cyt was calculated using the
equation derived by Grynkiewicz et al. [16].
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Measurements with calcium fluorophore fluo-4 in long-term
bone marrow cultures
To create a stromal layer, femur bones were excised
from mice (C57BL/6) and their medullar cavities were
aseptically flushed with Iscove's Modified Dulbecco's
Medium (IMDM). These cells were seeded on glass
coverslips (25 mm). The flasks were incubated (37 °C,
5 % CO2). Half of the media in each flask was replaced
weekly with equal amounts of fresh media. The IMDM
medium was supplemented with 5 % bovine fetal serum,
20 % horse serum and 10−6 M hydrocortisone. At the
end of the eighth week, after stroma formation, the
remaining hematopoietic cells were removed. New bone
marrow from additional mice was collected in IMDM
supplemented medium (10 ml) and cultured (2 h) in
tissue culture flasks (75 cm2). Non-adherent cells were
collected by removing the medium and were added
(106 cells per well) to the pre-cultured stroma [17].
For [Ca2+]cyt measurements, the cells were incubated
(40 min, at room temperature) with fluo-4/AM (10 μM)
and washed with Tyrode solution. Images were obtained
in two Z planes with a microscope equipped with a laser
scanner and an objective (Plan-Neofluor, 63x/1.43 numer-
ical aperture) under oil immersion (Leica, SP8, Germany).
The fluo-4 probe was excited at 488 nm and emission was
detected by using a bypass filter (λEm = 500–550 nm). The
pinhole device was not used for [Ca2+]cyt measurements.
Images were collected at 4.5 s intervals for about 2 min.
Fluorescence intensity was normalized by reference to the
basal fluorescence using Examiner 3.2 (Zeiss, Germany)
and Spectralyzer (Philadelphia, USA) software [17].
Flow cytometry analysis
To determine the level of P2 receptor expression in granu-
locytes, 106 bone marrow cells were fixed with 2 % formal-
dehyde for 30 min and permeabilized for 15 min with
0.01 % saponin. The cells were incubated for 2 h with rabbit
anti-P2Y IgG antibodies (6 μg/ml anti-P2Y1, 8 μg/ml anti-
P2Y2, 3 μg/ml anti-P2Y4, 6 μg/ml anti-P2Y6, 6 μg/ml anti-
P2Y11 and 8 μg/ml anti-P2Y12) in 1 % bovine serum albu-
min (BSA) dissolved in phosphate-buffered saline (PBS).
After addition of the first label, the cells were incubated for
40 min with Alexa Fluor 488-conjugated goat anti-rabbit
IgG antibody (4 μg/ml). The cells were then incubated for
20 min with rat Cy7/PE-conjugated anti-Gr-1 (2 μg/ml)
and rat PE-conjugated anti-Mac-1 (0.1 μg/ml). Ten
thousand Gr-1+Mac-1+ events were collected with a cyt-
ometer (FASCalibur, Becton Dickinson). Data analysis was
performed using CellQuest software (Becton Dickinson).
RNA extraction and reverse transcription polymerase
chain reaction (RT-PCR)
RNA extraction and RT-PCR were performed as previ-
ously described by Paredes-Gamero et al. [18] using the
same primers for P2Y1, P2Y2 and P2Y12 receptors. The fol-
lowing oligonucleotide primers were used for amplifying
nucleotide sequences of P2Y4 receptors: sense primer,
5’agcccaagttctggagatggtg3’; anti-sense primer, 5’ggtggttccat
tggcattgg3’ (GeneBank accession no. NM020621.3). The
PCR amplification of the nucleotide sequence of P2Y4 re-
ceptors was performed by incubating the samples at 94 °C
for 1 min followed by 35 cycles of 94 °C for 1 min
and 54 or 56 °C for 1 min, with a final incubation for
7 min at 72 °C. At the end of the amplification, the strands
were dissociated. Electrophoresis was performed in 1 %
agarose gel with a 100-bp DNA ladder as a size marker.
The bands were visualized with ethidium-bromide
staining.
Coimmunoprecipitation and western blotting
The granulocyte plasma membranes were disrupted with
a lysing buffer that contained a protease inhibitor cock-
tail (1 % Triton X-100, 10 % glycerol, 5 mM EDTA,
4 mM benzamidine, 5 mg/ml ε-aminocaproic acid,
10 mM iodoacetamide in 20 mM Tris buffer, pH 8.0).
The protein cell lysate (600 μg) was cleared by incuba-
tion (4 °C, 1 h) with rabbit normal serum (1:50). Protein
A-Sepharose was added and the unspecific immunopre-
cipitate was used as a negative control. Subsequently,
the lysate was incubated (4 °C, overnight) with rabbit
polyclonal anti-P2Y IgG (12 μg/ml anti-P2Y1, 16 μg/ml
anti-P2Y2, or 6 μg/ml anti-P2Y4) on a rotator. The
samples were then incubated (4 °C, 6 h) with protein A-
Sepharose (50 ml) on a rotator, centrifuged (700 × g,
2 min) and washed (3 times) with lysing buffer. The
immune-complex was eluted from the protein A-
Sepharose resin by adding the sample buffer (100 ml) for
SDS-PAGE under reduced conditions (40 % glycerol,
8 % SDS, 0.2 M Tris–HCl, pH 6.8 and 5 % β-
mercaptoethanol). The samples were boiled (5 min) to
release the immune-complex. Immunoprecipitated pro-
teins were added to SDS-PAGE (3–20 % acrylamide)
[19], and Western blot analysis was used to determine
whether the P2Y1 receptor interacted with other P2Y
receptors. The proteins were electrotransferred to a
nitrocellulose membrane. After blocking with non-fat
skimmed milk (5 % solution) in washing buffer (0.05 %
Tween in PBS), the receptors immunoprecipitated in the
blot were detected with rabbit anti-P2Y IgG (2 μg/ml
anti-P2Y1, 4 μg/ml anti-P2Y2 or 1 μg/ml anti-P2Y4) anti-
bodies. Subsequently, horseradish peroxidase-conjugated
goat anti-rabbit IgG was used as a secondary antibody
and the reactive bands were visible after addition of
enhanced chemiluminescent substrates.
A second sample was lysed as described above. After
centrifugation at 12,000 g for 15 min at 4 °C, the super-
natant containing the whole protein lysate (WP) was
saved. Protein A-Sepharose was incubated with goat
Ribeiro-Filho et al. BMC Pharmacology and Toxicology  (2016) 17:29 Page 3 of 11
polyclonal anti-P2Y1 (16 μg/ml) on a rotator. Further,
part of the WP (1,000 μg) was added and incubated at
4 °C for 12 h on a rotator, centrifuged (700 × g, 2 min)
and washed (3 times) with lysing buffer. The immune-
complex was eluted from the protein A-Sepharose resin
by adding 100 μL of the sample buffer [19] and boiled
for 5 min. Immunoprecipitated proteins and WP lysate
were added to 10 % SDS-PAGE. After transfer, the PVDF
membrane was blocked with blocking buffer (Odyssey™
Blocking Buffer- Li-COR) and incubated with rabbit
anti-P2Y2 IgG, washed with PBS-Twin, and incubated
with IRDye 800CW Donkey anti-Rabbit IgG (in green;
Li-COR). After stripping, the membrane was blocked
again and incubated with rabbit anti-P2Y1 IgG followed
by IRDye 680RD Donkey anti-Rabbit IgG (in red – LI-
COR). The fluorescence was read using the Odyssey
CLx® Infrared Imaging System (Li-COR).
Förster resonance energy transfer (FRET) assay
Granulocytes were fixed with 2 % formaldehyde for
30 min, washed with 0.1 % glycine, and permeabilized
with 0.01 % saponin for 15 min. The cells were incu-
bated for 2 h with goat anti-P2Y1 receptor (4 μg/ml,
Santa Cruz). Goat anti-IgG-Alexa Fluor 488 conjugated
antibody (Invitrogen, USA) was used for 40 min as
secondary antibody. Subsequently, rabbit anti-P2Y2 or
rabbit anti-P2Y4 were used (Alomone, Israel). Rabbit
anti-IgG-Alexa Fluor 546 conjugated antibody (Invitro-
gen, USA) was used for 40 min. Nuclei were stained
with DAPI (20 μg/ml, Sigma, USA) for 20 min. Light
microscopy analyses were performed with a confocal
laser scanning microscope equipped with a Plan-
Apochromat 63x objective (Leica, SP8). The pinhole de-
vice was adjusted to capture fluorescence of one Airy
unit in one focal section.
For FRET analysis, FRET signal was obtained at 488 nm
excitation employing an argon laser and the emitted fluor-
escence was detected from 560 nm to 650 nm in 10.6 nm
steps using the lambda modus. FRET ratios were calcu-
lated using the following equation: FRET ratio = Intensity
at 575 nm/Intensity at 521 nm [20].
In addition, emission spectra were measured at
488 nm excitation and the emission fluorescence was
detected from 515 nm to 600 nm in 1 nm steps using
FLEX station 3 (Molecular devices, USA). Fluorescence
intensities were normalized to the emission maximum of
the P2Y1 receptor (donor) at 525 nm. FRET ratios were
calculated using the following equation: FRET ratio =
Intensity at 575 nm/Intensity at 525 nm.
Purinergic quantification
Quantification of ATP and its analogs was carried out by
Liquid Chromatography-Electrospray Ionization Mass
Spectrometry (LC/ESI-MS) analysis as described previously
[21, 22]. Calibration samples of ATP and analogs, at
10−3 M concentration, were prepared in a water:-
methanol mixture (50:50 v/v). LC/ESI-MS data were ob-
tained on a Waters instrument, model 3100 coupled on a
Waters Alliance model 2695 system and a Waters de-
tector model 2847, using a Waters Nova-Pak C18 column
(2.1 × 150 mm, 60 Å, 3.5 μm); solvent A: aqueous DEA
(0.01 M) and solvent B: aqueous ammonium acetate
(0.1 M); 40 % B isocratic elution for 15 min, λ = 254 nm.
Mass measurements were performed in a negative mode
in the following conditions: mass range between 100 and
1000 m/z; nitrogen gas flow: 4.1 L/h; capillary: 3.9 kV;
cone voltage: 47 V; extractor: 8 V; source heater: 105 °C;
solvent heater: 400 °C; ion energy: 1.0 V and multiplier:
996 V.
Statistical analysis
In cell suspensions, cells were loaded with fura-2
fluorophore. The cytosolic Ca2+ values were expressed
as [Ca2+]cyt. In cells loaded with fluo-4 fluorophore,
[Ca2+]cyt values are shown as a representative pseudo-
colored image with reference to a fluorescence inten-
sity scale [0 = black, 255 = white], and the fluorescence
intensity is normalized by basal intensity.
Data are expressed as the mean ± standard error of the
mean (SEM). Statistical comparisons were performed
using Student’s T-test or analysis of variance (ANOVA),
with the Dunnett’s post hoc test. Values of P < 0.05 were
considered statistically significant. All graphical data
represent at least three independent experiments.
Results
Presence of P2Y receptors in granulocytes
Since most activated P2 receptors cause a [Ca2+]cyt
uptake, this calcium was monitored in granulocytes to
determine the P2 receptor subtypes expressed by these
cells. P2X agonists BzATP (10–100 μM), αβMeATP
(10–100 μM) and βγMeATP (1–10 μM) did not raise
the [Ca2+]cyt levels (Fig. 1a–c). High concentrations of
ATP, ADP and UTP (~100 μM to 1 mM) were required
to promote maximal increases in [Ca2+]cyt in granulo-
cytes (Fig. 1d–f ), as previously reported for some
hematopoietic cell types [5, 17, 18, 22–24]. When granu-
locytes were stimulated with a single application, con-
centrations of ATP, ADP and UTP around 1 mM
produced maximal increases in [Ca2+]cyt (Fig. 1d–f ).
Subsequent treatment with ATP (1 mM) and analogs
initially induced a transient increase in [Ca2+]cyt and
homologous desensitization (Fig. 1g–i).
ADP and UTP are typical P2Y agonists. To confirm
that the Ca2+ release is due the activation of P2Y recep-
tors, Pertusis toxin (PTX), a Gi protein-coupled receptor
inhibitor, and U73122, a PLC inhibitor were used. PTX
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and U73122 caused a decrease in the agonist-dependent
increases of [Ca2+]cyt (Fig. 1j–l).
The existence of P2Y receptors was confirmed by RT-
PCR and flow cytometry. RT-PCR assays showed expres-
sion of mRNA for ADP and UTP receptors: P2Y1, P2Y2,
P2Y4 and P2Y12 (Fig. 2a). Flow cytometry confirmed the
presence of P2Y1, P2Y2, P2Y4 and P2Y12 receptors in
granulocytes (Gr-1+Mac-1+ cells) of bone marrow at the
protein level (Fig. 2b). These are receptors activated by
ADP (P2Y1 and P2Y12) and UTP (P2Y2 and P2Y4).
Heteromeric association of P2Y1 receptor with P2Y2 and
P2Y4 receptors in granulocytes
Initially, cross-desensitization among ATP, ADP and
UTP was used to investigate the presence of distinct P2
receptors in granulocytes. As expected, ATP abolished
ADP and UTP responses (Fig. 3a, c). However, ADP and
UTP also completely abolished ATP responses (Fig. 3b, d).
Moreover, ADP and UTP showed full heterologous
desensitization (Fig. 3e, f ). These results suggested that
ADP and UTP act in the same P2Y receptor, though this
found was not observed in any other P2 receptors in
mammals.
Additionally, thapsigargin, a Ca2+-ATPase inhibitor,
avoided Ca2+ re-uptake into endoplasmatic reticulum,
showing that the lack of a second response to ADP and
UTP was not due to a deployment of intracellular Ca2+
stores or a technique artifact (Fig. 3g, h). To confirm
that the cross-desensitization between ADP and UTP
was a specific response, N-formyl-methionine-leucine-
phenylalanine (fMLP), another granulocyte-activation
related G-protein-coupled agonist, was used. No cross-
Fig. 1 Characterization of P2 responses in mice granulocytes. Granulocytes were loaded with the Ca2+ indicator fura-2. The P2X receptors agonists
a αβMeATP, b BzATP and c βγMeATP did not induce increases in [Ca2+]cyt. d–f Average increase in [Ca2+]cyt response to these agonists. However
g ATP, h ADP and i UTP were able to induce a transient increase in [Ca2+]cyt; one application of a high agonist concentration promoted
desensitization of the ATP response. j–l Granulocytes were pretreated for 3 h with PTX (0.05 μg/ml) or U73122 (5 μM). ATP and its analogs showed the
same sensitivity to Gi-coupled protein inhibitor PTX and PLC inhibitor U73122. These results are the means ± SEM of [Ca
2+]cyt increase above the resting
level. *P < 0.05, ANOVA test
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desensitization between fMLP with ADP or UTP was
observed (Fig. 3i–l). In addition, ATPγS, an analogue
of ATP that does not activate P2Y1 or P2Y2/P2Y4
receptors, did not promote cross-desensitization
(Fig. 3m, n). ADP and UTP (Fig. 3o–p). To evaluate
the participation of P2Y1 receptor, its specific
antagonist MRS2179 was used. MRS2179 was able to
abolish the ADP response (Fig. 3q), but not the UTP
response (Fig. 3r).
None of the P2 receptors are activated by both
ADP and UTP in mammals, except the P2y3 receptor
which was cloned from a chick brain [25] and was
activated by one as well as another. Another possibil-
ity is that the presence of a new P2Y receptor or
association of P2Y1 receptor with other UTP recep-
tors, such as P2Y2 or P2Y4 receptors, could change
their pharmacological characteristics, since homo- and
hetero-oligomerization is common for G protein-
coupled receptors [7].
To verify whether P2Y1 receptors were associated
with other P2Y receptors, a coimmunoprecipitation
assay was performed involving P2Y1, P2Y2 and P2Y4
receptors. P2Y1 receptor was immunoprecipitated
with P2Y2 and P2Y4 antibodies; immunoprecipitation
of P2Y2 and P2Y4 receptors were also reveled with
P2Y1 antibody (Fig. 4a). Additionally, an immunopre-
cipitation assay was performed using fluorescence
probes to confirm the presence of both receptors in
the same band; P2Y1 and P2Y2 receptor are present
together in the same band with a molecular weight
around 50 kDa (Fig. 4b). To corroborate this hypoth-
esis of the association of P2Y receptors a FRET assay
was employed. Confocal microscopy showed P2Y1/
P2Y2 and P2Y1/P2Y4 receptors colocalization (Fig. 4c
Merge), and FRET signal was obtained when the
sample was excited at 488 nm with the argon laser
(Donor: Alexa Fluor 488) and emission wavelength
was captured at 560–590 nm (Acceptor: Alexa Fluor
546 - emission of P2Y2 or P2Y4 receptor) (Fig. 4c).
Moreover, emission spectra of the samples were mea-
sured in a microplate spectrofluorometer. As observed
in Fig. 4d the sample labeled with antibodies P2Y1/
P2Y2 and P2Y1/P2Y4 showed a second peak at
575 nm of FRET signal. Quantification of FRET signal
is shown in Fig. 4e. Therefore, heteromeric associ-
ation between P2Y1 and P2Y2 or P2Y4 receptors also
occurred in the granulocytes. This could explain the
changes observed in the classical pharmacology of
P2Y receptors in mice granulocytes, where P2Y recep-
tors were simultaneously activated by ADP/UTP, but
with low affinity.
ATP and analogs are unstable compounds and as high
concentrations were used to stimulate granulocytes, it was
decided to quantify the presence of degraded products in
ATP, ADP and UTP by using liquid chromatography
coupled to mass spectrometry. Analytical evaluation
detected that the ATP sample (78 %) contains ADP
(9.6 %) and adenosine (3.5 %); ADP sample (88 %)
contains AMP (8.5 %) and adenosine (3.5 %); and
UTP sample (40 %) contains UDP (49 %) and UMP
(11 %). However, neither contamination of UTP was
detected in ADP sample and ADP was neither
detected in the UTP sample.
Fig. 2 Presence of P2Y receptors in bone marrow granulocytes.
a Granulocytes expressed mRNA for P2Y1, P2Y2, P2Y4 and P2Y12
receptors. Ladder 100-bp marker [M]; heart [H]; brain [B]; platelets [P];
granulocytes [G]. b To analyze the expression at the protein level of
P2Y receptors in Gr-1+Mac-1+ population (dot plot) flow cytometry
was used. Solid black histogram: negative control (preincubated
with the peptide antigen); open histogram: cells labeled with the
respective antibodies
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Heteromeric association may occur in mice myelocytic
progenitors
The effects of ADP and UTP on [Ca2+]cyt increase in
long-term bone marrow cultures containing myelocytic
progenitors were also analyzed. In these cultures, all
hematopoietic cells (smaller cells with circular shape)
were responsive to ATP, ADP and UTP showing the
same heterologous response observed in granulocytes
(Fig. 5). Heterologous desensitization was also observed
in many stromal cells (large cells with variable shapes) of
hematopoietic origin.
Discussion
The response exhibited by mice bone marrow granulo-
cytes during characterization of P2 receptors is unique
among mammalian P2 receptors. The avian P2y3 recep-
tor [25], ortholog of the mammalian P2Y6 receptor [26],
is the only known receptor activated by ADP and UTP.
Fig. 3 Cross-desensitization among ATP, ADP and UTP in mice granulocytes. Granulocytes were loaded with the Ca2+ indicator fura-2.
a–d Addition of ATP fully inhibited responses to ADP and UTP and vice-versa. e, f ADP and UTP showed full heterologous desensitization.
g, h Thapsigargin, a Ca2+-ATPase inhibitor, which releases Ca2+ from intracellular stores, showed that the lack of a second response was
not due to emptying of intracellular Ca2+ stores. i–l fMLP, another G-protein-coupled agonist, showed the specificity of cross-desensitization between
ADP and UTP. m, n ATPγS did not promote heterologous desensitization to ADP and UTP response. o, p Lower concentration of ADP and UTP
reduced responses to ADP and UTP. q, r MRS2179, a specific antagonist of the P2Y1 receptor, inhibited responses to ADP but not to UTP.
Granulocytes were pretreated for 30 min with MRS2179. All data are representative responses of at least four independent experiments
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The presence of a new receptor with distinct
pharmacological characteristics in granulocytes seems
to be unlikely. Therefore, we have presented another
possibility: the presence of direct or indirect hetero-
meric association among P2Y receptors. Among P2Y
receptors, ADP- (P2Y1) and UTP-activated (P2Y2 and
P2Y4) receptors were the most likely candidates. As
observed in Fig. 4, coimmunoprecipitation and FRET
assays revealed heteromeric association of P2Y1-P2Y2
and P2Y1-P2Y4 receptors. However, no association
between P2Y2 and P2Y4 receptors was observed
(Fig. 4a). Heteromeric associations involving P2Y1-
P2Y2 and P2Y1-P2Y4 receptors could account for the
unexpected pharmacology characteristic observed in
P2Y receptors in granulocytes.
Heterodimerization involving P2X receptors is already
known; the receptor heterodimers P2X2–3, P2X2–6,
P2X4–6 and P2X1–5 have been characterized extensively.
Heteromeric association between P2Y receptors has also
been observed in transfected systems, but it has never
been reported that this phenomenon occurs in primary
cells. Yoshioka et al. [3] observed heteromeric associ-
ation involving P2Y1 and A1 receptors after receptor
transfection of human embryonic kidney (HEK293T)
lineage cells. Ecke et al. [4], also working with trans-
fected HEK293 cells, described the first hetero-
Fig. 4 Heteromeric association among P2Y receptors. a Immunoprecipitation (IP) of cell lysates visualized by western blot (WB) analyses.
a Immunoprecipitated receptors P2Y2 and P2Y4 were visualized with an anti-P2Y1 antibody. P2Y1 receptors immunoprecipitated by the
same antibody were used as positive controls. Additionally, immunoprecipitated receptor P2Y1 was seen with either anti-P2Y2 or anti-P2Y4
antibodies. Unspecific immunoprecipitates of rabbit normal serum were used as negative controls (NC). b Immunopreciptation with infrared fluorescent
secondary antibody: P2Y1 receptors were immunopreciptated with goat antibodies. After SDS-PAGE the transferred proteins were revealed with rabbit
antibodies and analyzed with donkey anti-rabbit antibodies to different fluorophores. First for P2Y1 (red), and after membrane stripping for P2Y2 (green).
The whole protein lysate (WP) was used as a control. c Confocal images show the colocalization of P2Y1 receptor with P2Y2 or P2Y4 receptor. FRET signal
evidence that these receptors are spatially close. d To corroborate confocal images, emission spectra of samples are shown (Ex. 488). e Analysis of FRET
ratios were calculated as explained in the Methods section
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oligomerization among P2Y (P2Y1 and P2Y11) receptors.
Additionally, homodimeric and oligomer complexes
formed by P2Y2, P2Y4 and P2Y12 receptors may be typ-
ical for these receptors [5–7]. Among P2Y receptors,
P2Y4 and P2Y6 receptors have a secondary structure that
makes them likely to associate with other P2Y receptors
[7]. The present results support the hypothesis that het-
eromeric association among P2Y receptors is common
in bone marrow granulocytes.
Purinergic agonist affinity was low in granulocytes.
In some hematopoietic lineages (e.g., erythroid and
myeloid lineages), purinergic agonist affinity for P2Y
receptor has been found to be lower than in other
cell types [17, 18, 22–24, 27]. Homo- and hetero-
association between receptors could also have chan-
ged G-protein selectivity and agonist efficiency.
The fast degradation of ATP and analogs may be
related to the low activity observed by these agonists.
However, as no traces of UTP were detected in the
sample of ADP, or ADP in the sample of UTP,
desensitization by contamination was excluded.
Usually, P2Y1, P2Y2, P2Y4 and P2Y6 receptors are
associated with Gq/11 proteins, whereas P2Y11, P2Y12,
P2Y13 and P2Y14 receptors are associated with Gi pro-
teins. Murthy & Makhlouf [26] showed the complexity
of P2Y receptor signaling in smooth muscle cells, where
activation of P2Y2 receptors triggered both PLCβ1 via
Gα11 and PLCβ3 via Gβγi3. The occurrence of homo- and
hetero-association involving P2Y receptors would create
more opportunities for intracellular pathways associated
with these receptors. It is also necessary to account for
raft microdomains on the cellular membrane. Together
with the cytoplasm, these microdomains can create dis-
tinct intracellular pathways, thus explaining how similar
intracellular signaling systems can trigger different ef-
fects. This is supported by reports showing the presence
of P2Y homo-oligomers and homo-dimers in lipid raft
fractions [6, 7].
The presence of P2Y receptors in hematopoietic cells
supports the assertion that these receptors are involved
in proliferation and differentiation. The effect of ATP
has been studied in human myelocytic lineage HL-60,
Fig. 5 Heterologous desensitization between ADP and UTP also occurs in hematopoietic progenitor cells. Cells were loaded with the Ca2+ indicator
fluo-4, and intensity was measured with confocal microscopy (LSM 510 META). Scale bar = 20 μM. The images are a pseudocolored representation
in reference to the fluorescence intensity scale (0 = black, 255 =white). a Images in two Z planes showed cell preparations before agonist addition
(basal) and after stimulation (max) with 1 mM of ADP and UTP. b Records of fluorescence intensity as a function of time corresponded to images of
hematopoietic and stromal cells in a, and represented responses of four independent experiments
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which expresses P2Y2 receptors. Differentiation of HL-
60 cells to granulocytes did not alter P2Y2 receptor
expression. However, differentiation into monocytes/
macrophages decreased P2Y2 receptor expression [28].
Adrian et al. [29] showed alteration of expression of P2
receptors during granulocytic and monocytic differenti-
ation of HL-60 cells. Heterologous desensitization with
ADP and UTP was also observed on cobblestone areas
in long-term bone marrow cultures (Fig. 5), suggesting
that hetero-association may be present in primitive cells.
Recently, the participation of P2 receptors in differentiation
into myelocytes has been confirmed in hematopoietic stem
cells [17, 22, 24]. Hetero-association among P2Y receptors
would be a characteristic of the myelocytic lineage in mice.
Conclusion
The results of the present study demonstrate that
granulocytes express P2Y1, P2Y2 and P2Y4 receptor, and
heteromeric association between P2Y1/P2Y2 and P2Y1/
P2Y4 occur.
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